PortfoliosLab logo
ARQT vs. SHOP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ARQT and SHOP is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ARQT vs. SHOP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcutis Biotherapeutics, Inc. (ARQT) and Shopify Inc. (SHOP). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%150.00%December2025FebruaryMarchAprilMay
-38.00%
101.86%
ARQT
SHOP

Key characteristics

Sharpe Ratio

ARQT:

0.95

SHOP:

0.85

Sortino Ratio

ARQT:

1.78

SHOP:

0.94

Omega Ratio

ARQT:

1.20

SHOP:

1.13

Calmar Ratio

ARQT:

0.87

SHOP:

0.31

Martin Ratio

ARQT:

5.30

SHOP:

1.30

Ulcer Index

ARQT:

13.20%

SHOP:

16.55%

Daily Std Dev

ARQT:

73.21%

SHOP:

61.78%

Max Drawdown

ARQT:

-95.02%

SHOP:

-84.82%

Current Drawdown

ARQT:

-63.45%

SHOP:

-44.40%

Fundamentals

Market Cap

ARQT:

$1.82B

SHOP:

$128.10B

EPS

ARQT:

-$1.16

SHOP:

$1.55

PS Ratio

ARQT:

9.35

SHOP:

14.20

PB Ratio

ARQT:

11.66

SHOP:

10.87

Total Revenue (TTM)

ARQT:

$146.97M

SHOP:

$9.83B

Gross Profit (TTM)

ARQT:

$131.10M

SHOP:

$4.87B

EBITDA (TTM)

ARQT:

-$82.41M

SHOP:

$1.49B

Returns By Period

In the year-to-date period, ARQT achieves a -2.98% return, which is significantly higher than SHOP's -11.60% return.


ARQT

YTD

-2.98%

1M

1.69%

6M

29.95%

1Y

69.15%

5Y*

-11.25%

10Y*

N/A

SHOP

YTD

-11.60%

1M

21.94%

6M

9.88%

1Y

49.85%

5Y*

5.83%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ARQT vs. SHOP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARQT
The Risk-Adjusted Performance Rank of ARQT is 8282
Overall Rank
The Sharpe Ratio Rank of ARQT is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of ARQT is 8383
Sortino Ratio Rank
The Omega Ratio Rank of ARQT is 7676
Omega Ratio Rank
The Calmar Ratio Rank of ARQT is 8282
Calmar Ratio Rank
The Martin Ratio Rank of ARQT is 8888
Martin Ratio Rank

SHOP
The Risk-Adjusted Performance Rank of SHOP is 6969
Overall Rank
The Sharpe Ratio Rank of SHOP is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of SHOP is 6565
Sortino Ratio Rank
The Omega Ratio Rank of SHOP is 6666
Omega Ratio Rank
The Calmar Ratio Rank of SHOP is 6666
Calmar Ratio Rank
The Martin Ratio Rank of SHOP is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ARQT vs. SHOP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and Shopify Inc. (SHOP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ARQT Sharpe Ratio is 0.95, which is comparable to the SHOP Sharpe Ratio of 0.85. The chart below compares the historical Sharpe Ratios of ARQT and SHOP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.008.00December2025FebruaryMarchAprilMay
0.95
0.85
ARQT
SHOP

Dividends

ARQT vs. SHOP - Dividend Comparison

Neither ARQT nor SHOP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ARQT vs. SHOP - Drawdown Comparison

The maximum ARQT drawdown since its inception was -95.02%, which is greater than SHOP's maximum drawdown of -84.82%. Use the drawdown chart below to compare losses from any high point for ARQT and SHOP. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%December2025FebruaryMarchAprilMay
-63.45%
-44.40%
ARQT
SHOP

Volatility

ARQT vs. SHOP - Volatility Comparison

The current volatility for Arcutis Biotherapeutics, Inc. (ARQT) is 19.14%, while Shopify Inc. (SHOP) has a volatility of 22.37%. This indicates that ARQT experiences smaller price fluctuations and is considered to be less risky than SHOP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
19.14%
22.37%
ARQT
SHOP

Financials

ARQT vs. SHOP - Financials Comparison

This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and Shopify Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00B20212022202320242025
71.36M
2.81B
(ARQT) Total Revenue
(SHOP) Total Revenue
Values in USD except per share items

ARQT vs. SHOP - Profitability Comparison

The chart below illustrates the profitability comparison between Arcutis Biotherapeutics, Inc. and Shopify Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%100.0%20212022202320242025
90.3%
48.1%
(ARQT) Gross Margin
(SHOP) Gross Margin
ARQT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Arcutis Biotherapeutics, Inc. reported a gross profit of 64.46M and revenue of 71.36M. Therefore, the gross margin over that period was 90.3%.

SHOP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Shopify Inc. reported a gross profit of 1.35B and revenue of 2.81B. Therefore, the gross margin over that period was 48.1%.

ARQT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Arcutis Biotherapeutics, Inc. reported an operating income of -7.63M and revenue of 71.36M, resulting in an operating margin of -10.7%.

SHOP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Shopify Inc. reported an operating income of 465.00M and revenue of 2.81B, resulting in an operating margin of 16.5%.

ARQT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Arcutis Biotherapeutics, Inc. reported a net income of -10.79M and revenue of 71.36M, resulting in a net margin of -15.1%.

SHOP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Shopify Inc. reported a net income of 1.29B and revenue of 2.81B, resulting in a net margin of 46.0%.